This nested case-control study puts into perspective the diagnostic utility of the soluble FMS-like tyrosine kinase 1 serum test for preeclampsia.

***Note: Comments about this teaching resource, its content, and your thoughts can be made on this website (by registered users) or on Facebook (all users).

Estimated Time to View: 30 minutes
Title: Maternal serum soluble fms-like tyrosine kinase 1 concentrations are not increased in early pregnancy and decrease more slowly postpartum in women who develop preeclampsia
Citation: American Journal of Obstetrics and Gynecology 2005, Volume 193, pp. 185-91
Date Created: 2005
Revisions: None Indicated
Disclaimers: None
Resource Type: Text
Recommend to a Colleague/Friend

sflt1abstract sflt-figurea sflt-figure2

Transparent Peer Review

GD Star Rating

To learn more about our 6-point transparent peer review system, click here



  • Nephrology On-Demand Plus

    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


  • Kidney Konnection

    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
More in General Nephrology, Pregnancy (43 of 212 articles)